Fingerprint
Dive into the research topics of 'CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
Anjan Debnath, Claudia M. Calvet, Gareth Jennings, Wenxu Zhou, Alexander Aksenov, Madeline R. Luth, Ruben Abagyan, W. David Nes, James H. McKerrow, Larissa M. Podust
Research output: Contribution to journal › Article › peer-review
41
Scopus
citations